Experimental and Molecular Medicine

Korean Society for Biochemistry and Molecular Biongy (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer

  • Lee, Hyun Ju (Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital) ;
  • Hong, Cheol Yi (Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital) ;
  • Kim, Mi-Hyun (Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital) ;
  • Lee, Youn-Kyung (Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital) ;
  • Nguyen-Pham, Thanh-Nhan (Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital) ;
  • Park, Byoung Chul (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Yang, Deok-Hwan (Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital) ;
  • Chung, Ik-Joo (Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital) ;
  • Kim, Hyeoung-Joon (Department of Hematology-Oncology, Chonnam National University Hwasun Hospital) ;
  • Lee, Je-Jung (Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital)
  • Accepted : 2011.11.09
  • Published : 2012.01.31
⟨ Previous Next ⟩

Abstract

Anterior gradient-2 (AGR2) promotes tumor growth, cell migration, and cellular transformation, and is one of the specific mRNA markers for circulating tumor cells in patients with gastrointestinal cancer. We investigated the feasibility of AGR2 as a potent antigen for tumor immunotherapy against colorectal cancer (CRC) cells using dendritic cells (DCs) transduced with a recombinant adenovirus harboring the AGR2 gene (AdAGR2). DCs transduced with a recombinant adenovirus encoding the AGR2 gene (AdAGR2/DCs) were characterized. These genetically-modified DCs expressed AGR2 mRNA as well as AGR2 protein at a multiplicity of infection of 1,000 without any significant alterations in DC viability and cytokine secretion (IL-10 and IL-12p70) compared with unmodified DCs as a control. In addition, AdAGR2 transduction did not impair DC maturation, but enhanced expression of HLA-DR, CD80, and CD86. AdAGR2/DCs augmented the number of IFN-${\gamma}$-secreting T-cells and elicited potent AGR2-specific cytotoxic T lymphocytes capable of lysing AGR2-expressing CRC cell lines. These results suggest that AGR2 act as a potentially important antigen for immunotherapy against CRC in clinical applications.

Keywords

References

  1. Aberger F, Weidinger G, Grunz H, Richter K. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech Dev 1998;72: 115-30 https://doi.org/10.1016/S0925-4773(98)00021-5
  2. Aicher A, Westermann J, Cayeux S, Willimsky G, Daemen K, Blankenstein T, et al. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp Hematol 1997;25:39-44
  3. Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 1997;186:1177- 82 https://doi.org/10.1084/jem.186.7.1177
  4. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005;5:296-306 https://doi.org/10.1038/nri1592
  5. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999;10:440-7 https://doi.org/10.1016/S0958-1669(99)00007-5
  6. Di Nicola M, Siena S, Bregni M, Longoni P, Magni M, Milanesi M, et al. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors. Cancer Gene Ther 1998;5:350-6
  7. Eloit M, Gilardi-Hebenstreit P, Toma B, Perricaudet M. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J Gen Virol 1990;71:2425-31 https://doi.org/10.1099/0022-1317-71-10-2425
  8. Gong J, Chen L, Chen D, Kashiwaba M, Manome Y, Tanaka T, et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Ther 1997;4: 1023-8 https://doi.org/10.1038/sj.gt.3300496
  9. Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterol 2006;131:925-33 https://doi.org/10.1053/j.gastro.2006.04.026
  10. Hirschowitz EA, Weaver JD, Hidalgo GE, Doherty DE. Murine dendritic cells infected with adenovirus vectors show signs of activation. Gene Ther 2000;7:1112-20 https://doi.org/10.1038/sj.gt.3301210
  11. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res 2005;65:3796-805 https://doi.org/10.1158/0008-5472.CAN-04-3823
  12. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 1991;145: 185-92 https://doi.org/10.1016/0022-1759(91)90325-A
  13. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1995;1:1297-302 https://doi.org/10.1038/nm1295-1297
  14. Melief CJ, Van Der Burg SH, Toes RE, Ossendorp F, Offringa R. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol Rev 2002;188:177-82 https://doi.org/10.1034/j.1600-065X.2002.18816.x
  15. Muthuswamy R, Urban J, Lee JJ, Reinhart TA, Bartlett D, Kalinski P. Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res 2008;68:5972-8 https://doi.org/10.1158/0008-5472.CAN-07-6818
  16. Nakamura M, Iwahashi M, Nakamori M, Ueda K, Ojima T, Naka T, et al. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptidepulsed DCs. Oncology 2005;68:163-70 https://doi.org/10.1159/000086770
  17. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32 https://doi.org/10.1038/nm0398-328
  18. Oh ST, Kim CH, Park MY, Won EH, Sohn HJ, Cho HI, et al. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide. Vaccine 2006;24:2860-8 https://doi.org/10.1016/j.vaccine.2005.12.056
  19. Parmiani G, De Filippo A, Novellino L, Castelli C. Unique human tumor antigens: immunobiology and use in clinical trials. J Immunol 2007;178:1975-9 https://doi.org/10.4049/jimmunol.178.4.1975
  20. Ramachandran V, Arumugam T, Wang H, Logsdon CD. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res 2008;68:7811-8 https://doi.org/10.1158/0008-5472.CAN-08-1320
  21. Rea D, Schagen FH, Hoeben RC, Mehtali M, Havenga MJ, Toes RE, et al. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J Virol 1999;73:10245-53
  22. Rosenberg SA. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol Today 1997;18:175-82 https://doi.org/10.1016/S0167-5699(97)84664-6
  23. Song W, Kong HL, Carpenter H, Torii H, Granstein R, Rafii S, et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 1997;186:1247-56 https://doi.org/10.1084/jem.186.8.1247
  24. Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991;5:344-66 https://doi.org/10.1002/jcla.1860050510
  25. Valladares-Ayerbes M, Diaz-Prado S, Reboredo M, Medina V, Iglesias-Diaz P, Lorenzo-Patino MJ, et al. Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer. Cancer Detect Prev 2008;32:236-50 https://doi.org/10.1016/j.cdp.2008.08.002
  26. Yi Q, Bergenbrant S, Osterborg A, Osby E, Ostman R, Bjorkholm M, et al. T-cell stimulation induced by idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies. Scand J Immunol 1993;38:529-34 https://doi.org/10.1111/j.1365-3083.1993.tb03236.x
  27. Zhang Y, Forootan SS, Liu D, Barraclough R, Foster CS, Rudland PS, et al. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis 2007;10:293-300 https://doi.org/10.1038/sj.pcan.4500960
  28. Zhong L, Granelli-Piperno A, Choi Y, Steinman RM. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur J Immunol 1999;29:964-72 https://doi.org/10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P

Cited by

  1. Generation of Potent Cytotoxic T Lymphocytes Against Castration‐Resistant Prostate Cancer Cells by Dendritic Cells Loaded With Dying Allogeneic Prostate Cancer Cells vol.77, pp.2, 2012, https://doi.org/10.1111/sji.12007
  2. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker vol.15, pp.2, 2012, https://doi.org/10.1186/bcr3408
  3. Anterior Gradient Protein-2 Is a Regulator of Cellular Adhesion in Prostate Cancer vol.9, pp.2, 2012, https://doi.org/10.1371/journal.pone.0089940
  4. Dendritic Cells Induce Specific Cytotoxic T Lymphocytes against Prostate Cancer TRAMP-C2 Cells Loaded with Freeze-thaw Antigen and PEP-3 Peptide vol.16, pp.2, 2012, https://doi.org/10.7314/apjcp.2015.16.2.571
  5. Elevated NLR May Be a Feature of Pediatric Brain Cancer Patients vol.9, pp.None, 2012, https://doi.org/10.3389/fonc.2019.00327
  6. Leveraging the Role of the Metastatic Associated Protein Anterior Gradient Homologue 2 in Unfolded Protein Degradation: A Novel Therapeutic Biomarker for Cancer vol.11, pp.7, 2012, https://doi.org/10.3390/cancers11070890